Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Psychoneuroendocrinology. 2017 Apr 29;82:17–25. doi: 10.1016/j.psyneuen.2017.04.011

Table 4.

Associations between subgroup membership and cardio-metabolic outcomes

Metabolic Syndrome Obesity
OR 95% CI p-value OR 95% CI p-value
Model 1
  Age 1.005 0.993–1.018 0.384 0.995 0.983–1.007 0.413
  Gender 0.588 0.454–0.762 <0.001* 0.825 0.637–1.067 0.143
  Education 0.646 0.498–0.839 0.001* 0.722 0.557–0.936 0.014
  Employment 1.061 0.803–1.402 0.679 1.163 0.881–1.535 0.287
  Marital Status 1.210 0.909–1.611 0.191 0.992 0.748–1.315 0.954
  Race 1.349 0.948–1.92 0.096 2.111 1.492–2.986 <0.001*
  Ethnicity 0.742 0.342–1.608 0.449 0.911 0.432–1.92 0.806
  Presence of Chronic Conditions 1.517 1.166–1.973 0.002* 1.151 0.884–1.498 0.296
  Antidepressant Use 1.573 1.087–2.276 0.016* 1.445 1.002–2.086 0.049*
Model 2¥
  Mild Symptoms Subgroup 1.240 0.923–1.665 0.154 1.359 1.015–1.821 0.040*
  Moderate Symptoms Subgroup 1.571 1.023–2.413 0.039* 1.491 0.973–2.283 0.066
  Acute Symptoms Subgroup 1.752 0.750–4.093 0.195 1.297 0.56–3.004 0.544
Model 3¥
  Regular Exercise 0.606 0.445–0.824 <0.001* 0.541 0.399–0.735 <0.001*
  Current Smoking 0.863 0.587–1.268 0.453 0.551 0.371–0.82 0.003*
  Drinker (past month) 0.723 0.552–0.946 0.018* 0.890 0.68–1.166 0.398
  Mild Symptoms Subgroup 1.225 0.909–1.65 0.182 1.345 1–1.808 0.050
  Moderate Symptoms Subgroup 1.595 1.032–2.463 0.035* 1.555 1.008–2.4 0.046*
  Acute Symptoms Subgroup 1.653 0.697–3.923 0.254 1.280 0.539–3.038 0.576
Model 3¥,
  C-reactive Protein 1.780 1.551–2.043 <0.001* 2.080 1.801–2.402 <0.001*
  Mild Symptoms Subgroup 1.218 0.895–1.657 0.210 1.347 0.986–1.842 0.061
  Moderate Symptoms Subgroup 1.400 0.891–2.201 0.144 1.325 0.835–2.103 0.232
  Acute Symptoms Subgroup 1.963 0.791–4.873 0.146 1.551 0.6–4.008 0.365
*

p<0.05;

OR=Odds Ratio; Low/No Symptoms Subgroup is reference group;

¥

controlled for age, gender, education, employment, marital status, race, ethnicity, antidepressant use and presence of chronic conditions;

controlled for health behaviors.